Sign in or create an account to add this stock to your watchlist.
About Nu Skin Enterprises (NYSE:NUS)
Nu Skin Enterprises, Inc. develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems and targeted treatment products, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic, personal care, and hair care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, and LifePak nutritional supplements, as well as other anti-aging nutritional solutions and weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates walk-in centers and pick-up locations; and retail stores and service centers in Mainland China. The company sells its products directly, as well as through distributors and Website. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
Industry, Sector and Symbol
Industry Drugs, proprietaries, & sundries
Sub-IndustryPersonal Products
SectorConsumer Staples
SymbolNYSE:NUS
CUSIP67018T10
Phone801-345-1000
Debt
Debt-to-Equity Ratio0.13
Current Ratio1.14
Quick Ratio0.75
Price-To-Earnings
Trailing P/E Ratio24.79
Forward P/E Ratio22.49
P/E Growth2.72
Sales & Book Value
Annual Sales$2.28 billion
Price / Sales1.95
Cash Flow$4.6776 per share
Price / Cash17.12
Book Value$14.37 per share
Price / Book5.57
Profitability
EPS (Most Recent Fiscal Year)$3.23
Net Income$129.43 million
Net Margins5.74%
Return on Equity25.36%
Return on Assets11.54%
Miscellaneous
Employees4,700
Outstanding Shares55,610,000
Nu Skin Enterprises (NYSE:NUS) Frequently Asked Questions
What is Nu Skin Enterprises' stock symbol?
Nu Skin Enterprises trades on the New York Stock Exchange (NYSE) under the ticker symbol "NUS."
How often does Nu Skin Enterprises pay dividends? What is the dividend yield for Nu Skin Enterprises?
Nu Skin Enterprises declared a quarterly dividend on Friday, April 27th. Stockholders of record on Friday, May 25th will be given a dividend of $0.365 per share on Wednesday, June 13th. This represents a $1.46 annualized dividend and a dividend yield of 1.82%. The ex-dividend date is Thursday, May 24th. View Nu Skin Enterprises' Dividend History.
How were Nu Skin Enterprises' earnings last quarter?
Nu Skin Enterprises, Inc. (NYSE:NUS) issued its quarterly earnings results on Thursday, April, 26th. The company reported $0.79 EPS for the quarter, topping the consensus estimate of $0.70 by $0.09. The company had revenue of $616 million for the quarter, compared to analysts' expectations of $564.46 million. Nu Skin Enterprises had a net margin of 5.74% and a return on equity of 25.36%. The company's revenue for the quarter was up 23.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.51 earnings per share. View Nu Skin Enterprises' Earnings History.
When is Nu Skin Enterprises' next earnings date?
What guidance has Nu Skin Enterprises issued on next quarter's earnings?
Nu Skin Enterprises issued an update on its FY18 earnings guidance on Thursday, April, 26th. The company provided EPS guidance of $3.73-3.93 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.61. The company issued revenue guidance of $2.51-2.56 billion, compared to the consensus revenue estimate of $2.47 billion.Nu Skin Enterprises also updated its Q2 guidance to $0.91-0.96 EPS.
What price target have analysts set for NUS?
5 equities research analysts have issued 1-year price targets for Nu Skin Enterprises' stock. Their predictions range from $57.00 to $90.00. On average, they anticipate Nu Skin Enterprises' stock price to reach $72.60 in the next twelve months. View Analyst Ratings for Nu Skin Enterprises.
What are Wall Street analysts saying about Nu Skin Enterprises stock?
Here are some recent quotes from research analysts about Nu Skin Enterprises stock:
- 1. According to Zacks Investment Research, "Nu Skin is a premier anti-aging company. The company's anti-aging products feature the ageLOC line of products including ageLOC Tru Face Essence Ultra firming serum, the ageLOC TR90 weight management and body shaping system, ageLOC R2 nutritional supplement, and ageLOC Transformation daily skin care system. " (2/28/2018)
- 2. Pivotal Research analysts commented, "We think 2018 might be bigger than usual – for Repo which again, is not in guidance." (2/16/2018)
Who are some of Nu Skin Enterprises' key competitors?
Who are Nu Skin Enterprises' key executives?
Nu Skin Enterprises' management team includes the folowing people:
- Mr. Steven J. Lund, Exec. Chairman (Age 65)
- Mr. Ritch N. Wood, CEO & Director (Age 52)
- Mr. Ryan S. Napierski, Pres (Age 44)
- Dr. Joseph Y. Chang, Exec. VP of Product Devel. & Chief Scientific Officer (Age 65)
- Mr. D. Matthew Dorny, Exec. VP, Gen. Counsel & Sec. (Age 54)
Has Nu Skin Enterprises been receiving favorable news coverage?
Headlines about NUS stock have been trending somewhat positive on Sunday, according to Accern Sentiment Analysis. The research firm scores the sentiment of media coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Nu Skin Enterprises earned a media sentiment score of 0.19 on Accern's scale. They also assigned news articles about the company an impact score of 47.37 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the near term.
Who are Nu Skin Enterprises' major shareholders?
Nu Skin Enterprises' stock is owned by many different of retail and institutional investors. Top institutional investors include BlackRock Inc. (9.90%), JPMorgan Chase & Co. (2.22%), Dimensional Fund Advisors LP (2.17%), Old Mutual Global Investors UK Ltd. (1.33%), Wasatch Advisors Inc. (1.26%) and Prudential Financial Inc. (0.81%). Company insiders that own Nu Skin Enterprises stock include Andrew D Lipman, D Matthew Dorny, Daniel W Campbell, Joseph Y Chang, Mark H Lawrence, Pisano R Thomas, Ryan S Napierski and Steven Lund. View Institutional Ownership Trends for Nu Skin Enterprises.
Which major investors are selling Nu Skin Enterprises stock?
NUS stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Old Mutual Global Investors UK Ltd., Schroder Investment Management Group, JPMorgan Chase & Co., Robertson Opportunity Capital LLC, Riverhead Capital Management LLC, Chicago Equity Partners LLC and Glen Harbor Capital Management LLC. Company insiders that have sold Nu Skin Enterprises company stock in the last year include D Matthew Dorny, Daniel W Campbell, Joseph Y Chang, Mark H Lawrence, Pisano R Thomas, Ryan S Napierski and Steven Lund. View Insider Buying and Selling for Nu Skin Enterprises.
Which major investors are buying Nu Skin Enterprises stock?
NUS stock was purchased by a variety of institutional investors in the last quarter, including Millennium Management LLC, Mackay Shields LLC, OppenheimerFunds Inc., Russell Investments Group Ltd., Schwab Charles Investment Management Inc., Landscape Capital Management L.L.C., Dimensional Fund Advisors LP and New York State Common Retirement Fund. View Insider Buying and Selling for Nu Skin Enterprises.
How do I buy shares of Nu Skin Enterprises?
Shares of NUS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Nu Skin Enterprises' stock price today?
One share of NUS stock can currently be purchased for approximately $80.08.
How big of a company is Nu Skin Enterprises?
Nu Skin Enterprises has a market capitalization of $4.50 billion and generates $2.28 billion in revenue each year. The company earns $129.43 million in net income (profit) each year or $3.23 on an earnings per share basis. Nu Skin Enterprises employs 4,700 workers across the globe.
How can I contact Nu Skin Enterprises?
Nu Skin Enterprises' mailing address is 75 WEST CENTER ST, PROVO UT, 84601. The company can be reached via phone at 801-345-1000 or via email at [email protected]
MarketBeat Community Rating for Nu Skin Enterprises (NUS)
MarketBeat's community ratings are surveys of what our community members think about Nu Skin Enterprises and other stocks. Vote "Outperform" if you believe NUS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NUS will underperform the S&P 500 over the long term. You may vote once every thirty days.
Nu Skin Enterprises (NYSE:NUS) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
5 Wall Street analysts have issued ratings and price targets for Nu Skin Enterprises in the last 12 months. Their average twelve-month price target is $72.60, suggesting that the stock has a possible downside of 9.34%. The high price target for NUS is $90.00 and the low price target for NUS is $57.00. There are currently 2 sell ratings, 1 hold rating and 2 buy ratings for the stock, resulting in a consensus rating of "Hold."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Hold | Hold | Hold | Hold |
| Consensus Rating Score: | 2.00 | 2.00 | 2.17 | 2.00 |
| Ratings Breakdown: | 2 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s) | 2 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s) | 2 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s) | 2 Sell Rating(s)
2 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | $72.60 | $72.40 | $70.1667 | $60.6667 |
| Price Target Upside: | 9.34% downside | 3.71% downside | 0.22% upside | 2.34% downside |
Nu Skin Enterprises (NYSE:NUS) Consensus Price Target History
Nu Skin Enterprises (NYSE:NUS) Analyst Ratings History
Show:
(Data available from 5/27/2016 forward)
Nu Skin Enterprises (NYSE:NUS) Dividend Information
Nu Skin Enterprises pays an annual dividend of $1.46 per share, with a dividend yield of 1.82%. NUS's next quarterly dividend payment will be made on Wednesday, June 13. The company has grown its dividend for the last 17 consecutive years and is increasing its dividend by an average of 1.40% each year. Nu Skin Enterprises pays out 45.20% of its earnings out as a dividend.
| Next Dividend: | 6/13/2018 |
| Annual Dividend: | $1.46 |
| Dividend Yield: | 1.82% |
| Dividend Growth: | 1.40% (3 Year Average) |
| Payout Ratio(s): | 45.20% (Trailing 12 Months of Earnings)
41.01% (Based on This Year's Estimates)
37.15% (Based on Next Year's Estimates)
31.21% (Based on Cash Flow)
|
| Track Record: | 17 Years of Consecutive Dividend Growth |
| Frequency: | Quarterly Dividend |
Nu Skin Enterprises (NYSE:NUS) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 4/27/2018 | quarterly | $0.3650 | 2.06% | 5/24/2018 | 5/25/2018 | 6/13/2018 |
| 2/16/2018 | quarterly | $0.3650 | 2.11% | 2/23/2018 | 2/26/2018 | 3/14/2018 |
| 11/2/2017 | quarterly | $0.36 | 2.37% | 11/16/2017 | 11/17/2017 | 12/6/2017 |
| 8/3/2017 | quarterly | $0.36 | 2.35% | 8/23/2017 | 8/25/2017 | 9/13/2017 |
| 5/4/2017 | quarterly | $0.36 | 2.65% | 5/24/2017 | 5/26/2017 | 6/14/2017 |
| 2/16/2017 | quarterly | $0.36 | 2.99% | 2/23/2017 | 2/27/2017 | 3/15/2017 |
| 11/4/2016 | quarterly | $0.3550 | 2.65% | 11/16/2016 | 11/18/2016 | 12/7/2016 |
| 8/5/2016 | quarterly | $0.3550 | 2.39% | 8/24/2016 | 8/26/2016 | 9/14/2016 |
| 4/29/2016 | quarterly | $0.3550 | 3.48% | 5/25/2016 | 5/27/2016 | 6/8/2016 |
| 2/12/2016 | quarterly | $0.3550 | 4.87% | 2/24/2016 | 2/26/2016 | 3/16/2016 |
| 10/30/2015 | quarterly | $0.35 | 3.66% | 11/18/2015 | 11/20/2015 | 12/9/2015 |
| 8/7/2015 | quarterly | $0.35 | 2.96% | 8/26/2015 | 8/28/2015 | 9/16/2015 |
| 5/7/2015 | quarterly | $0.35 | 2.59% | 5/20/2015 | 5/22/2015 | 6/10/2015 |
| 2/6/2015 | quarterly | $0.35 | 2.65% | 2/25/2015 | 2/27/2015 | 3/18/2015 |
| 11/5/2014 | quarterly | $0.3450 | 3.4% | 11/19/2014 | 11/21/2014 | 12/3/2014 |
| 8/19/2014 | quarterly | $0.3450 | 2.78% | 9/10/2014 | 9/12/2014 | 9/26/2014 |
| 5/7/2014 | quarterly | $0.3450 | 1.77% | 5/21/2014 | 5/23/2014 | 6/11/2014 |
| 3/3/2014 | quarterly | $0.3450 | 1.85% | 3/12/2014 | 3/14/2014 | 3/26/2014 |
| 10/30/2013 | quarterly | $0.30 | 1.02% | 11/20/2013 | 11/22/2013 | 12/4/2013 |
| 8/1/2013 | quarterly | $0.30 | 1.36% | 8/21/2013 | 8/23/2013 | 9/11/2013 |
| 5/9/2013 | quarterly | $0.30 | 2.1% | 5/22/2013 | 5/24/2013 | 6/12/2013 |
| 2/12/2013 | quarterly | $0.30 | 2.8% | 2/20/2013 | 2/22/2013 | 3/13/2013 |
(Data available from 1/1/2013 forward)
Nu Skin Enterprises (NYSE NUS) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 5.20%
Institutional Ownership Percentage: 76.82%
Nu Skin Enterprises (NYSE NUS) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 5/10/2018 | D Matthew Dorny | General Counsel | Sell | 3,500 | $76.87 | $269,045.00 | 33,871 |  |
| 5/3/2018 | D Matthew Dorny | General Counsel | Sell | 13,000 | $73.81 | $959,530.00 | 44,371 | |
| 4/4/2018 | D Matthew Dorny | General Counsel | Sell | 2,000 | $75.00 | $150,000.00 | 47,878 | |
| 4/4/2018 | Steven Lund | Chairman | Sell | 81,000 | $75.00 | $6,075,000.00 | 4,769 | |
| 4/2/2018 | D Matthew Dorny | General Counsel | Sell | 3,250 | $72.22 | $234,715.00 | | |
| 3/9/2018 | Mark H Lawrence | CFO | Sell | 724 | $72.86 | $52,750.64 | 11,473 | |
| 3/7/2018 | Pisano R Thomas | Director | Sell | 15,000 | $72.00 | $1,080,000.00 | 47,437 | |
| 3/5/2018 | D Matthew Dorny | General Counsel | Sell | 3,000 | $72.69 | $218,070.00 | 44,399 | |
| 1/22/2018 | Steven Lund | Chairman | Sell | 22,891 | $70.08 | $1,604,201.28 | 4,769 | |
| 1/19/2018 | Steven Lund | Chairman | Sell | 13,978 | $70.01 | $978,599.78 | 4,769 | |
| 12/27/2017 | Steven Lund | Chairman | Sell | 8,977 | $70.04 | $628,749.08 | 4,769 | |
| 12/22/2017 | Steven Lund | Chairman | Sell | 108,132 | $68.81 | $7,440,562.92 | 4,769 | |
| 12/20/2017 | Steven Lund | Chairman | Sell | 42,000 | $68.11 | $2,860,620.00 | 4,769 | |
| 11/10/2017 | Joseph Y Chang | Insider | Sell | 36,503 | $62.24 | $2,271,946.72 | 66,563 | |
| 11/8/2017 | Joseph Y Chang | Insider | Sell | 13,497 | $62.06 | $837,623.82 | 66,563 | |
| 11/1/2017 | Ryan S Napierski | President | Sell | 11,667 | $63.84 | $744,821.28 | 71,634 | |
| 10/10/2017 | Ryan S Napierski | President | Sell | 6,933 | $64.00 | $443,712.00 | | |
| 9/7/2017 | Daniel W Campbell | Director | Sell | 4,607 | $62.48 | $287,845.36 | 63,753 | |
| 8/10/2017 | D Matthew Dorny | General Counsel | Sell | 7,500 | $60.88 | $456,600.00 | 52,230 | |
| 7/25/2017 | Ryan S Napierski | President | Sell | 8,000 | $65.00 | $520,000.00 | 68,170 | |
| 7/5/2017 | D Matthew Dorny | General Counsel | Sell | 8,250 | $62.92 | $519,090.00 | 46,730 | |
| 6/5/2017 | D Matthew Dorny | General Counsel | Sell | 8,000 | $56.39 | $451,120.00 | 52,730 | |
| 5/11/2017 | D Matthew Dorny | General Counsel | Sell | 8,000 | $58.32 | $466,560.00 | 53,730 | |
| 4/3/2017 | D Matthew Dorny | General Counsel | Sell | 8,000 | $55.30 | $442,400.00 | 53,730 | |
| 3/6/2017 | D Matthew Dorny | General Counsel | Sell | 16,000 | $50.00 | $800,000.00 | 45,730 | |
| 2/16/2017 | Ryan S Napierski | Insider | Sell | 8,400 | $55.00 | $462,000.00 | 48,905 | |
| 1/6/2017 | D Matthew Dorny | General Counsel | Sell | 8,000 | $50.00 | $400,000.00 | 49,230 | |
| 12/13/2016 | D Matthew Dorny | General Counsel | Sell | 20,000 | $50.10 | $1,002,000.00 | 41,230 | |
| 10/26/2016 | Steven Lund | Chairman | Sell | 61,000 | $61.55 | $3,754,550.00 | | |
| 9/22/2016 | Andrew D Lipman | Director | Sell | 30,000 | $64.13 | $1,923,900.00 | 36,090 | |
| 3/8/2016 | Ritch N Wood | CFO | Buy | 7,500 | $33.32 | $249,900.00 | 50,996 | |
| 3/4/2016 | Joseph Y Chang | Insider | Sell | 20,000 | $34.21 | $684,200.00 | 43,613 | |
| 8/18/2015 | Scott E. Schwerdt | insider | Sell | 18,750 | $45.96 | $861,750.00 | 34,585 | |
| 7/6/2015 | Daniel R Chard | Insider | Sell | 17,500 | $46.67 | $816,725.00 | | |
| 11/26/2014 | Ritch N Wood | CFO | Buy | 2,500 | $43.03 | $107,575.00 | | |
| 11/14/2013 | D Matthew Dorny | General Counsel | Sell | 20,000 | $112.50 | $2,250,000.00 | 30,255 | |
| 10/22/2013 | Steven Lund | Chairman | Sell | 50,000 | $117.33 | $5,866,500.00 | | |
| 9/6/2013 | Steven Lund | Chairman | Sell | 47,000 | $86.07 | $4,045,290.00 | | |
| 8/22/2013 | Daniel Campbell | Director | Sell | 8,203 | $86.82 | $712,184.46 | 51,000 | |
| 8/21/2013 | Patricia Negron | Director | Sell | 5,000 | $86.20 | $431,000.00 | 7,192 | |
| 8/6/2013 | Steven Lund | Chairman | Sell | 40,000 | $87.33 | $3,493,200.00 | 4,053 | |
(Data available from 1/1/2013 forward)
Nu Skin Enterprises (NYSE NUS) News Headlines
| Source: |
|
| Date | Headline |
|---|
 | Nu Skin Enterprises (NUS) and Trxade Group (TRXD) Financial Analysis
www.americanbankingnews.com - May 27 at 1:18 AM |
| Nu Skin Enterprises, Inc. (NUS) Expected to Announce Quarterly Sales of $647.30 Million
www.americanbankingnews.com - May 25 at 4:57 AM |
 | Nu Skin Enterprises To Present At RBC Capital Markets Consumer And Retail Conference
finance.yahoo.com - May 24 at 5:53 PM |
| $0.89 Earnings Per Share Expected for Nu Skin Enterprises (NUS) This Quarter
www.americanbankingnews.com - May 23 at 3:16 AM |
| Nu Skin Enterprises (NUS) Given Average Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - May 21 at 3:34 PM |
 | Analysis: Positioning to Benefit within United Natural Foods, Capitol Federal Financial, Royal Gold, Celsion, National ...
globenewswire.com - May 15 at 8:10 AM |
| Analysis: Positioning to Benefit within United Natural Foods, Capitol Federal Financial, Royal Gold, Celsion, National CineMedia, and Nu Skin Enterprises — Research Highlights Growth, Revenue, and Consolidated Results
finance.yahoo.com - May 15 at 8:10 AM |
| Nu Skin Enterprises (NUS) General Counsel D Matthew Dorny Sells 3,500 Shares
www.americanbankingnews.com - May 14 at 7:59 PM |
| Free Post Earnings Research Report: Kimberly-Clark’s Revenues Soared 5%
finance.yahoo.com - May 7 at 8:09 AM |
| Zacks: Brokerages Anticipate Nu Skin Enterprises (NUS) Will Announce Quarterly Sales of $647.30 Million
www.americanbankingnews.com - May 7 at 2:32 AM |
| Zacks: Analysts Anticipate Nu Skin Enterprises (NUS) Will Announce Earnings of $0.89 Per Share
www.americanbankingnews.com - May 5 at 5:08 PM |
| Nu Skin Enterprises (NUS) General Counsel D Matthew Dorny Sells 13,000 Shares
www.americanbankingnews.com - May 4 at 7:32 PM |
| Nu Skin Enterprises (NUS) Given New $82.00 Price Target at Citigroup
www.americanbankingnews.com - April 30 at 8:55 AM |
| Head-To-Head Review: PetIQ (PETQ) & Nu Skin Enterprises (NUS)
www.americanbankingnews.com - April 28 at 5:08 PM |
 | BRIEF-Nu Skin Enterprises Q1 Earnings Per Share $0.64
www.reuters.com - April 28 at 8:11 AM |
| Nu Skin Enterprises (NUS) Issues Quarterly Earnings Results
www.americanbankingnews.com - April 27 at 7:52 PM |
| Nu Skin Enterprises (NUS) Plans $0.37 Quarterly Dividend
www.americanbankingnews.com - April 27 at 6:00 PM |
| Edited Transcript of NUS earnings conference call or presentation 26-Apr-18 9:00pm GMT
finance.yahoo.com - April 27 at 5:23 PM |
| Nu Skin: 1Q Earnings Snapshot
finance.yahoo.com - April 27 at 8:11 AM |
| Nu Skin Enterprises (NUS) Updates Q2 Earnings Guidance
www.americanbankingnews.com - April 26 at 6:14 PM |
| Nu Skin Enterprises (NUS) Releases FY18 Earnings Guidance
www.americanbankingnews.com - April 26 at 6:14 PM |
| Nu Skin Enterprises Reports Strong First-Quarter Results And Increases Annual Guidance
finance.yahoo.com - April 26 at 5:25 PM |
| Nu Skin Enterprises (NUS) Given Consensus Recommendation of "Hold" by Analysts
www.americanbankingnews.com - April 26 at 3:30 PM |
| Nu Skin Enterprises (NUS) Set to Announce Earnings on Tuesday
www.americanbankingnews.com - April 24 at 6:13 AM |
| BRIEF-Nu Skin Enterprises Enters Into A Credit Agreement That Provides For A $400 Million Term Loan Facility
www.reuters.com - April 23 at 5:22 PM |
 | Can Solid Sales Endeavors Fuel Nu Skin (NUS) Q1 Earnings?
www.nasdaq.com - April 23 at 5:22 PM |
 | Dividend Analysis: Nu Skin Enterprises
www.msn.com - April 21 at 8:08 AM |
| Analysts Expect Nu Skin Enterprises (NUS) Will Announce Quarterly Sales of $561.32 Million
www.americanbankingnews.com - April 20 at 2:16 AM |
| Nu Skin Enterprises (NUS) Expected to Announce Earnings of $0.67 Per Share
www.americanbankingnews.com - April 18 at 5:12 PM |
| Nu Skin Enterprises (NUS) Stock Rating Lowered by BidaskClub
www.americanbankingnews.com - April 14 at 9:51 PM |
| Stifel Nicolaus Analysts Give Nu Skin Enterprises (NUS) a $50.00 Price Target
www.americanbankingnews.com - April 13 at 9:27 PM |
| Nu Skin Enterprises (NUS) Downgraded to "Hold" at Deutsche Bank
www.americanbankingnews.com - April 13 at 10:37 AM |
| Nu Skin Enterprises (NUS) Upgraded to "B" at TheStreet
www.americanbankingnews.com - April 13 at 10:15 AM |
| Stock Traders Purchase Large Volume of Nu Skin Enterprises Put Options (NUS)
www.americanbankingnews.com - April 12 at 7:01 AM |
| Nu Skin Enterprises (NUS) Downgraded by Zacks Investment Research to Sell
www.americanbankingnews.com - April 7 at 12:39 AM |
| Insider Selling: Nu Skin Enterprises (NUS) General Counsel Sells 2,000 Shares of Stock
www.americanbankingnews.com - April 5 at 10:21 PM |
| Steven Lund Sells 81,000 Shares of Nu Skin Enterprises (NUS) Stock
www.americanbankingnews.com - April 5 at 10:20 PM |
| Nu Skin Enterprises (NUS) General Counsel Sells $234,715.00 in Stock
www.americanbankingnews.com - April 3 at 10:26 PM |
| Nu Skin Enterprises (NUS) Upgraded by ValuEngine to Strong-Buy
www.americanbankingnews.com - April 3 at 11:06 AM |
| Nu Skin Enterprises (NUS) Expected to Announce Quarterly Sales of $561.32 Million
www.americanbankingnews.com - April 3 at 2:44 AM |
| $0.67 Earnings Per Share Expected for Nu Skin Enterprises (NUS) This Quarter
www.americanbankingnews.com - April 1 at 5:10 PM |
| Nu Skin Enterprises (NUS) Earns "Buy" Rating from Citigroup
www.americanbankingnews.com - March 26 at 8:46 PM |
| Nu Skin Enterprises To Report First-Quarter 2018 Results
finance.yahoo.com - March 26 at 5:31 PM |
| Brokerages Anticipate Nu Skin Enterprises, Inc. (NUS) Will Post Quarterly Sales of $561.32 Million
www.americanbankingnews.com - March 17 at 7:11 AM |
| Nu Skin Enterprises, Inc. (NUS) Expected to Announce Earnings of $0.67 Per Share
www.americanbankingnews.com - March 15 at 3:54 PM |
| Insider Selling: Nu Skin Enterprises, Inc. (NUS) CFO Sells 724 Shares of Stock
www.americanbankingnews.com - March 12 at 8:18 PM |
| Nu Skin Enterprises To Present At Bank Of America Merrill Lynch 2018 Consumer And Retail Technology Conference
finance.yahoo.com - March 8 at 6:59 PM |
| Insider Selling: Nu Skin Enterprises, Inc. (NUS) Director Sells 15,000 Shares of Stock
www.americanbankingnews.com - March 8 at 6:29 PM |
| Nu Skin Enterprises, Inc. (NUS) Receives Consensus Rating of "Hold" from Brokerages
www.americanbankingnews.com - March 7 at 3:45 PM |
| Nu Skin Enterprises, Inc. (NUS) General Counsel D Matthew Dorny Sells 3,000 Shares
www.americanbankingnews.com - March 6 at 6:50 PM |
Nu Skin Enterprises (NYSE:NUS) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Nu Skin Enterprises (NYSE:NUS) Income Statement, Balance Sheet and Cash Flow Statement
Nu Skin Enterprises (NYSE NUS) Stock Chart for Sunday, May, 27, 2018
Loading chart…
